BOSTON--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today reported GAAP earnings per share from continuing operations of $.23 on revenue of $386.9 million for the third quarter ended October 1, 2006. The third quarter 2006 results include intangibles amortization of $9.1 million, or approximately $.05 per share, and stock option expense of $3.1 million, or $.02 per share. The Company announced earnings per share from continuing operations excluding intangibles amortization and stock option expense, or Cash EPS, of $.30, which represents an increase of 25% over the third quarter of 2005 and exceeded the Company’s forecasted range of $.27 to $.29.
